Deirdre Weymann
Biographic Data
| ID | 5537742 |
|---|---|
| NAME | Deirdre Weymann |
| GIVEN NAMES | Deirdre |
| FAMILY NAME | Weymann |
| SIGNATURE | WEYMANN D |
| AFFILIATIONS | Canadian Centre for Applied Research in Cancer Control |
| ORCID | 0000-0002-3072-5657 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing
INTRODUCTION: Genetic testing for hereditary cancer syndromes (HCSs) can improve health outcomes through cancer risk mitigation strategies. Effective communication between tested individuals and their family members is key to reducing the hereditary cancer burden. Our objective was to develop a patient portal to improve familial communication for patients undergoing HCS genetic testing, followed by an early-phase evaluation. METHODS: The portal w…
Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
Genetic testing for hereditary cancer syndromes
BACKGROUND: Multi-gene panel testing is replacing single-gene testing for patients with suspected hereditary cancer syndromes. The detection of a hereditary cancer syndrome allows tested individuals to initiate enhanced primary and secondary prevention efforts-where available-with a view to reduce disease burden. Current policy prevents testing programmes from communicating genetic test results with potentially affected family members, yet it is …
Allocating healthcare resources to genomic testing in Canada
Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada
OBJECTIVES: We quantify patterns in prescription opioid dispensations to individuals who suffered a prescription opioid-related death. In addition, we examine the relationship between opioid dispensations and prescription opioid-related deaths in geographic regions of British Columbia (BC). METHODS: We used population-based administrative data on prescription drug dispensations to identify patterns in prescription opioid dispensations to individu…
No prominent works on this page.
Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada
OBJECTIVES: We quantify patterns in prescription opioid dispensations to individuals who suffered a prescription opioid-related death. In addition, we examine the relationship between opioid dispensations and prescription opioid-related deaths in geographic regions of British Columbia (BC). METHODS: We used population-based administrative data on prescription drug dispensations to identify patterns in prescription opioid dispensations to individu…
Allocating healthcare resources to genomic testing in Canada
Genetic testing for hereditary cancer syndromes
BACKGROUND: Multi-gene panel testing is replacing single-gene testing for patients with suspected hereditary cancer syndromes. The detection of a hereditary cancer syndrome allows tested individuals to initiate enhanced primary and secondary prevention efforts-where available-with a view to reduce disease burden. Current policy prevents testing programmes from communicating genetic test results with potentially affected family members, yet it is …
Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing
INTRODUCTION: Genetic testing for hereditary cancer syndromes (HCSs) can improve health outcomes through cancer risk mitigation strategies. Effective communication between tested individuals and their family members is key to reducing the hereditary cancer burden. Our objective was to develop a patient portal to improve familial communication for patients undergoing HCS genetic testing, followed by an early-phase evaluation. METHODS: The portal w…
Medicine (5 works) · Cancer (3 works) · Genomics and Rare Diseases (3 works) · Internal Medicine (3 works) · Biology (2 works) · BRCA gene mutations in cancer (2 works) · Computer Science (2 works) · Genetic counseling (2 works) · Genetic testing (2 works) · Genetics (2 works)